Exposure to a common fungal molecule can reprogram immune cells in the lungs, causing them to overreact to infection-like ...

DURING SCREENING SEASON, which runs from March to December, LUCAS sets off on Mondays from the cancer institute in Morgantown ...

Trained immunity in alveolar macrophages can lead to damaging lung inflammation, confirming the importance of context in this phenomenon.

The UAB researchers showed that TREM2 — which stands for triggering receptors expressed on myeloid cells 2 — is predominantly ...

Unlike a bulla, which is a distal acinar (or paraseptal) emphysematous lung lesion, the displacement caused by subpleural interstitial emphysema is generally small in size, i.e., 1-2 cm in diameter ...

Vaping may seem cool to young kids and teenager, but it can have a lasting impact on their health. This 24-year-old took to ...

Dr. Radhika Banka, Consultant, Respiratory Physician at P.D. Hinduja Hospital, Mahim, tells India Today 10 ways how smoking ...

The aim is to find and treat lung cancers early, before they grow and spread, to improve the chance of survival. Here’s ...

Dr. Radhika Banka, Consultant, Respiratory Physician at PD Hinduja Hospital & Medical Research Centre, Mahim, told IndiaToday ...

FDA approves Dupixent for treating bullous pemphigoid in adults, showing significant improvements in disease management. Quiver AI Summary The U.S. Food and Drug Administration (FDA) has approved ...

By addressing two central drivers of the underlying type 2 inflammation that contributes to bullous pemphigoid, Dupixent is the first targeted medicine to allow patients the potential to achieve ...

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid Approval based on pivotal results showing improvements in sustained disease remission and reductions ...